BioSpace News Archive

Pharm Country

Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced that it has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on June 20-22, 2023.

June 8, 2023
·
1 min read
Genetown

Regulatory Authorities in China and Japan Approve Clinical Trials for Anthos Therapeutics’ Dual-Acting Factor XI/XIa Inhibitor Abelacimab

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced two important regulatory milestones in China and Japan for clinical trials of the company’s investigational agent, abelacimab.

June 8, 2023
·
10 min read
Drug Development

Nature Medicine Publishes Results from Pivotal Phase 3 LAVENDER™ Study Evaluating DAYBUE™ (trofinetide) Efficacy and Safety in Patients with Rett Syndrome

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Nature Medicine published results from the pivotal Phase 3 LAVENDER™ trial, a 12-week randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of DAYBUE™ in patients with Rett syndrome five to 20 years of age.

June 8, 2023
·
11 min read
Business

Nephron Announces New President of 503B Outsourcing Facility

Nephron Pharmaceuticals Corporation announced Christopher Fortier, PharmD, FASHP, CPEL, will join as President of its 503B Outsourcing Facility.

June 8, 2023
·
2 min read
BioCapital

Somatus Expands Multi-State Value-Based Kidney Care Partnership with Kidney Care Center

Somatus, the nation’s leading and largest value-based kidney care company, and Kidney Care Center announced a significant expansion to their existing collaborative efforts.

June 8, 2023
·
5 min read
EMRIS Pharma, the Recent Spin-off of Hadasit and Yissum, Launches the Development of a New Innovative topical drug for the Treatment of Skin Toxicities, Improving Treatment and Quality of Life for Cancer Patients

Hadasit, and Yissum, has spun off EMRIS Pharma in collaboration with NGT Healthcare2 VC.

June 8, 2023
·
5 min read
Hyloris has been granted EUR 1 million in non-dilutive funding from the Walloon Region

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announced that the Company has been granted EUR 1 million in non-dilutive funding from the Walloon Region for the first part of the development of HY-083.

June 8, 2023
·
5 min read
Business

Inspired Spine Surgery Center announces grand opening of state-of-the-art facility

Inspired Spine Surgery Center is proud to announce the grand opening of its brand-new facility in Burnsville, MN.

June 8, 2023
·
2 min read
Eitan Medical Completes Transition of Wearable Injectors Business

Eitan Medical is pleased to announce the successful completion of sale and transition of its wearable injectors business to LTS, a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems.

June 8, 2023
·
3 min read
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

A study put out by researchers at the University of Texas MD Anderson Cancer Center recently detailed a previously unexplained type of cell death that could open the door for novel cancer therapies.

June 8, 2023
·
11 min read